These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Serum angiotensin converting enzyme activity in chronic beryllium disease. Newman LS; Orton R; Kreiss K Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822 [TBL] [Abstract][Full Text] [Related]
26. [Differential diagnosis of berylliosis/sarcoidosis in a dental technician]. Müller-Quernheim J; Zissel G; Schopf R; Vollmer E; Schlaak M Dtsch Med Wochenschr; 1996 Nov; 121(47):1462-6. PubMed ID: 8983896 [TBL] [Abstract][Full Text] [Related]
27. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529 [TBL] [Abstract][Full Text] [Related]
28. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445 [TBL] [Abstract][Full Text] [Related]
29. Reversible beryllium sensitization in a prospective study of beryllium workers. Rom WN; Lockey JE; Bang KM; Dewitt C; Johns RE Arch Environ Health; 1983; 38(5):302-7. PubMed ID: 6651355 [TBL] [Abstract][Full Text] [Related]
30. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014 [TBL] [Abstract][Full Text] [Related]
31. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects. Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069 [TBL] [Abstract][Full Text] [Related]
32. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942 [TBL] [Abstract][Full Text] [Related]
37. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis. Verma DK; Ritchie AC; Shaw ML Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557 [TBL] [Abstract][Full Text] [Related]
38. Short- and long-term response to corticosteroid therapy in chronic beryllium disease. Marchand-Adam S; El Khatib A; Guillon F; Brauner MW; Lamberto C; Lepage V; Naccache JM; Valeyre D Eur Respir J; 2008 Sep; 32(3):687-93. PubMed ID: 18757698 [TBL] [Abstract][Full Text] [Related]
39. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Fontenot AP; Kotzin BL; Comment CE; Newman LS Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947 [TBL] [Abstract][Full Text] [Related]
40. A 65-year-old factory worker with dyspnea on exertion and a normal chest x-ray. Saber W; Dweik RA Cleve Clin J Med; 2000 Nov; 67(11):791-2, 794, 797-8, 800. PubMed ID: 11104328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]